Menopause

Graphic image of an arrow nailing the bullseye of a target

AbCellera tops ‘most aggressive’ hopes, putting rivals on notice

AbCellera saw phase 2 results “beyond even the most aggressive upside scenario” that its CEO had considered, sending shares up 30% in pre-market trading.

Nick Paul Taylor Aug 10, 2026 8:24am

HHS cancels contracts for largest women’s health effort in US

Apr 23, 2025 11:48am

Bayer posts pivotal data on rival to Astellas in menopause space

May 17, 2024 6:45am

gold rocks gold rush bonanza mining precious metals

Bayer to take menopause drug to regulators after 3rd ph. 3 win

Mar 19, 2024 7:17am

First Lady Jill Biden State of the Union Maria Shriver

Biden asks Congress for $12B to fund women's health research

Mar 8, 2024 10:25am

Bayer hits hot flash phase 3 goals to stay on Astellas’ heels

Jan 8, 2024 10:16am